Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04143152 · ClinicalTrials.gov registry record
Pancreatic Cancer Biomarker Study
A clinical trial of Pancreatic Adenocarcinoma, sponsored by Van Andel Research Institute.
- Active
- Registry status
- 300
- Enrollment target
- 1
- Study location
NCT04143152 is a study of Pancreatic Adenocarcinoma that is active but no longer recruiting, run by Van Andel Research Institute. The registered enrollment target is 300 participants, below the 99,460-participant average among 62 other Pancreatic Adenocarcinoma trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04143152, a study of Pancreatic Adenocarcinoma, is active but no longer recruiting, sponsored by Van Andel Research Institute.
- ACTIVE NOT RECRUITING
- Registry status
- 300 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a non-treatment, blood collection study to evaluate biomarker panels for the diagnosis and prognosis of pancreatic cancer.
Conditions Studied
Study Locations (1)
Michigan
- Mercy Health Saint Mary's Hospital - Grand Rapids
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2021-01-01 |
| Est. Completion | 2024-10-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04143152
The ClinicalTrials.gov registry entry for NCT04143152 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 99,460-participant average among 62 other Pancreatic Adenocarcinoma trials with a reported enrollment target (100% lower). The listed sponsor is Van Andel Research Institute, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Pancreatic Adenocarcinoma appearing as the primary indexed condition, and to 0 interventions.
NCT04143152 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.
Frequently Asked Questions
What is clinical trial NCT04143152 about?
NCT04143152 is a clinical study titled "Pancreatic Cancer Biomarker Study". This is a non-treatment, blood collection study to evaluate biomarker panels for the diagnosis and prognosis of pancreatic cancer.
What is the current status of trial NCT04143152?
This trial is currently active not recruiting. The enrollment target is 300 participants. The study started on 2021-01-01. Estimated completion is 2024-10-31.
What conditions does trial NCT04143152 study?
This clinical trial studies the following conditions: Pancreatic Adenocarcinoma.
Who is sponsoring clinical trial NCT04143152?
This trial is sponsored by Van Andel Research Institute, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04143152 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pancreatic Adenocarcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Alpha Radiation Emitters Device for the Treatment of Pancreatic Cancer With Chemotherapy for the Treatment of Locally Advanced and Metastatic Pancreatic Cancer
RECRUITING · NA
-
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
RECRUITING · Phase 1
-
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
RECRUITING · Phase 1
-
A Study of NT-175 in Adult Subjects With Unresectable, Advanced, and/or Metastatic Solid Tumors That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
RECRUITING · Phase 1
-
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
RECRUITING · Phase 1
-
Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.